Skip to main content
. 2017 Oct 10;8(55):94619–94634. doi: 10.18632/oncotarget.21816

Figure 2. Cellular activities of LY2510924 peptide and LY2624587 antibody.

Figure 2

Flow cytometry analysis of cell surface CXCR4 protein expression (PE) following exposure to (A) LY2510924 (peptide antagonist) and (B) LY2624587 (CXCR4 mAb). Isotype control Ab = red, untreated cells = blue, treated cells = orange (A) or green (B). (C) Human B cell lymphoma Raji cell death 48 hours following exposure to LY2510924 (peptide antagonist) or LY2624587 (CXCR4 mAb) versus PBS control. NS = not significant.